Affinity Asset Advisors »

Boundless Bio shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Boundless Bio (BOLD) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Boundless Bio

Tip: Access up to 7 years of quarterly data

All positions including Boundless Bio held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Boundless Bio by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $625k 250k 2.50

More positions owned by Affinity Asset Advisors

Roivant Sciences SHS (ROIV)
Apogee Therapeutics (APGE)
Spyre Therapeutics Com New (SYRE)
Xenon Pharmaceuticals (XENE)
Erasca (ERAS)
Alkermes SHS (ALKS)
Insmed Com Par $.01 (INSM)
Moderna Put Option (MRNA)
Praxis Precision Medicines I Com New (PRAX)
Oruka Therapeutics (ORKA)
Anaptysbio Inc Common (ANAB)
Avalo Therapeutics Com New (AVTX)
Cytokinetics Com New (CYTK)
Revolution Medicines (RVMD)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Affinity Asset Advisors

Top funds holding Boundless Bio

FMR
Arch Venture Corp
Tang Capital Management
ADAR1 Capital Management
Sectoral Asset Management
Vanguard Capital Management
Wellington Management Company
Renaissance Technologies
Alyeska Investment Group
Affinity Asset Advisors
Rbf Capital
Ensign Peak Advisors
Sio Capital Management
Stonepine Capital Management
Citadel Advisors

View all funds holding Boundless Bio